34-member consortium creates an interoperable data standard for AI and distributed analytics Guardant Health, Inc. a leading precision oncology company, announced the public launch of
After 25+ years in VA infectious diseases and national leadership, Echevarria joins Bitscopic to help VAMCs strengthen antimicrobial stewardship programs (ASP) with PraediAlert. Bitscopic announced the
GenomOncology has entered a strategic partnership with the Glioblastoma Foundation to enhance genomic testing for glioblastoma, the most aggressive type of brain cancer. This collaboration
Hammes, a national firm specializing in real estate consulting, development, investment, and management, announced that Justin Franklin has joined Hammes Healthcare as a vice president
RADPAIR, a company specializing in generative AI for radiology reporting, has introduced PAIRsdk, a new developer framework designed to accelerate the implementation of Agentic AI
Lapsi Health, a Dutch-American health technology company, has joined forces with eMurmur, a Canadian-Austrian leader in AI for cardiac and pulmonary auscultation, to integrate eMurmur’s
HealthTree Foundation, a global nonprofit organization that brings together scattered medical records to help speed up research on blood cancer, has announced new connections with
House Rx, a healthcare technology company focused on improving access and affordability for specialty medications, has raised $55 million in Series B equity and debt
Luma Health has officially bought Tonic Health from R1, a company known for its work with dynamic intake, e-consents, and patient-reported outcomes. This move supports
Despite long-standing medical advice against doing routine endoscopies for simple heartburn, new national data from Motive Medical Intelligence show that millions of Americans with uncomplicated
Acquisition supplements CIMAR’s cloud-native infrastructure with DeepHealth’s AI-powered informatics to deliver connected, efficient and accessible care RadNet, Inc., a US leader in providing high-quality, cost-effective
Pluri launches wholly-owned health and aesthetics subsidiary Cellav- leveraging Pluri’s proprietary 3D cell expansion platform to deliver advanced exosome-based technologies for medical aesthetics Pluri Inc.,
